Abeona Therapeutics Inc (ABEO)
4.60
+0.53
(+13.02%)
USD |
NASDAQ |
May 03, 16:00
4.61
+0.01
(+0.22%)
After-Hours: 20:00
Abeona Therapeutics Cash from Operations (TTM): -37.01M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -37.01M |
| September 30, 2023 | -41.77M |
| June 30, 2023 | -42.81M |
| March 31, 2023 | -41.54M |
| December 31, 2022 | -43.48M |
| September 30, 2022 | -59.75M |
| June 30, 2022 | -63.29M |
| March 31, 2022 | -65.77M |
| December 31, 2021 | -65.66M |
| September 30, 2021 | -37.02M |
| June 30, 2021 | -37.39M |
| March 31, 2021 | -35.37M |
| December 31, 2020 | -35.02M |
| September 30, 2020 | -47.66M |
| June 30, 2020 | -55.21M |
| March 31, 2020 | -60.97M |
| December 31, 2019 | -62.82M |
| September 30, 2019 | -65.54M |
| June 30, 2019 | -56.33M |
| March 31, 2019 | -50.11M |
| December 31, 2018 | -39.11M |
| September 30, 2018 | -27.19M |
| June 30, 2018 | -24.92M |
| March 31, 2018 | -20.88M |
| December 31, 2017 | -22.66M |
| Date | Value |
|---|---|
| September 30, 2017 | -21.00M |
| June 30, 2017 | -18.22M |
| March 31, 2017 | -16.36M |
| December 31, 2016 | -13.01M |
| September 30, 2016 | -12.50M |
| June 30, 2016 | -11.02M |
| March 31, 2016 | -9.776M |
| December 31, 2015 | -10.42M |
| September 30, 2015 | -8.648M |
| June 30, 2015 | -6.276M |
| March 31, 2015 | -4.649M |
| December 31, 2014 | -1.611M |
| September 30, 2014 | -0.983M |
| June 30, 2014 | -1.759M |
| March 31, 2014 | 0.222M |
| December 31, 2013 | 0.001M |
| September 30, 2013 | -1.141M |
| June 30, 2013 | -0.707M |
| March 31, 2013 | -3.219M |
| December 31, 2012 | -3.955M |
| September 30, 2012 | -4.303M |
| June 30, 2012 | -6.818M |
| March 31, 2012 | -7.854M |
| December 31, 2011 | -7.609M |
| September 30, 2011 | -7.361M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-65.77M
Minimum
Mar 2022
-35.02M
Maximum
Dec 2020
-50.23M
Average
-47.66M
Median
Sep 2020
Cash from Operations (TTM) Benchmarks
| T2 Biosystems Inc | -48.14M |
| INVO Bioscience Inc | -4.755M |
| Perspective Therapeutics Inc | -36.91M |
| Electromed Inc | 4.872M |
| Xtant Medical Holdings Inc | -9.515M |